On a Friday in early December, a federal advisory panel in the United States moved to set aside a practice that had guided newborn care for more than three decades: giving every infant a hepatitis B shot at birth. The change arrives in a country where the disease has grown quieter, and quiet is precisely what makes it hard to judge. Whether the old protection was a victory to be retired or a safeguard whose success is the reason it seems unnecessary is a question the coming years will have to answer.
Fact-Checking the CDC Panel's Case for Ending Universal Newborn Hepatitis B Vaccination
Infected infants face roughly a 90% chance of developing chronic hepatitis B, and about a quarter of those may die prematurely from the disease.
"This disease has become a victim of the vaccine."
Mark
What actually changed on Dec. 5?
Mimi
The advisory committee ended the universal recommendation that every newborn get a hepatitis B dose at birth, a policy dating to about 1991. Mothers who test negative are now told to discuss it with their doctors, and the first dose, if skipped at birth, comes no earlier than 2 months.
Mark
Why does the panel's makeup matter here?
Mimi
Secretary Kennedy fired all 17 prior members in June and chose the replacements. That is context for the vote, though the fact-check itself focuses on the claims made.
Luke
Careful, though. The source establishes who appointed them, not that appointment explains the vote.
Mark
Fair. What about the argument that some children are low-risk?
Mimi
The fact-check says risk is hard to know. The virus can live on surfaces for a week and infections can be silent. About half of the 640,000 adults with chronic infection don't know it.
Luke
That 640,000 is a CDC estimate, and the half-unaware share is too. Those are estimates, not counts.
Mark
And the Denmark comparison?
Mimi
Denmark doesn't include the vaccine for all babies, but 116 of 194 WHO member states do. The U.S. also lacks a national health system and has lower prenatal screening rates.
Luke
Worth noting the source doesn't say how much those differences would change outcomes here. And no one can yet say whether infections will rise after this change; Meissner's warning is a prediction.
Mimi
Right. What is documented is the drop from about 20,000 infected children a year to very few.
Il Polso
- A federal panel voted to end the universal hepatitis B birth dose that has stood since about 1991, and the decision landed quickly on the families and doctors who must now decide.
- Fact-checkers say the case for dropping the shot rests on a 'low-risk' idea that cannot be reliably seen from outside a household, since the virus can linger on surfaces and hide silently for years.
- Doctors warn that infants who contract the virus face a 90% chance of chronic infection, with a grim share dying young, and that the disease's current rarity is the result of the vaccine itself.
- The new guidance pushes first doses to 2 months or later for babies whose mothers test negative, and the country is now watching whether infection rates among the youngest children begin to climb.
On a Friday in early December, a federal advisory panel in the United States moved to set aside a practice that had guided newborn care for more than three decades: giving every infant a hepatitis B shot at birth. The change arrives in a country where the disease has grown quieter, and quiet is precisely what makes it hard to judge. Whether the old protection was a victory to be retired or a safeguard whose success is the reason it seems unnecessary is a question the coming years will have to answer.
On Friday, December 5, a CDC advisory committee voted to end a policy that had been in place since about 1991: the recommendation that every baby born in the United States receive a hepatitis B vaccine at birth. Under the new guidance, mothers who test negative for the virus are told to talk with their doctors about whether their newborns need the shot, and babies who skip the birth dose would get their first dose no earlier than two months of age.
The panel that cast this vote is not the one that existed last spring. Health Secretary Robert F. Kennedy Jr. dismissed all 17 members of the previous committee in June and installed his own appointees. PolitiFact examined four claims raised during the Dec. 4 and 5 discussions, and found most of them wanting.
The central argument was that some children are 'low-risk' and do not need the vaccine. But risk is hard to read from the outside. Hepatitis B spreads through blood and other bodily fluids, survives on surfaces for up to a week, and can hide for years. About half of the 640,000 adults with chronic infection do not know they have it. Before universal birth dosing, only about half of infected children under 10 had caught the virus from their mothers at birth, so a negative maternal test does not close every route.
The disease is most dangerous to the newest lives. Infected infants have a 90% chance of becoming chronically ill, and about a quarter of them die young. Pediatric infectious disease specialist Dr. James Campbell offered the starkest comparison: where roughly 18,000 to 20,000 children a year were once born with the infection, now there are almost none.
That near-absence is the reason the vaccine's critics see little need for it, and the reason its defenders fear it. Dr. H. Cody Meissner, who voted against the change, warned that the disease has become a victim of its own success and will return if the schedule loosens. Other countries, including Denmark, were cited in defense of the change, yet most WHO member states still give a universal birth dose, and Denmark's national health system makes prenatal screening and record-keeping far easier than they are in the U.S.
What happens next will be measured in the youngest children. If first doses slip to two months or later for many babies, the coming years will show whether the quiet holds.
On Friday, Dec. 5, a CDC advisory committee voted to undo a policy that had stood since roughly 1991: the recommendation that every baby born in the United States receive a hepatitis B vaccine dose at birth. The Advisory Committee on Immunization Practices now says mothers who test negative for the virus should talk with their doctors about whether their newborns need the shot. For babies who skip a birth dose, the panel suggested the first dose come no earlier than 2 months of age.
The committee that cast the vote is not the one that existed last spring. Health and Human Services Secretary Robert F. Kennedy Jr., a longtime anti-vaccine advocate, fired all 17 members of the prior panel in June and installed his own picks. PolitiFact, in a piece carried by PBS News, examined four claims that surfaced during the panel's discussions on Dec. 4 and 5.
The first concerned the idea of the "low-risk" child. Several committee members and health administrators questioned whether children they described that way needed the vaccine. But exposure risk is hard to read from the outside. Hepatitis B spreads through bodily fluids such as blood, semen and vaginal fluids, and it is a tough virus that can survive on surfaces for up to a week. Traces of dried blood on a nail clipper, razor or toothbrush could be enough. The infection can also be silent for years. The CDC estimates about 640,000 adults have chronic infections, and about half of them do not know it, meaning they can pass it on unaware. A negative test in the mother does not close off other routes, either. Before universal birth dosing, only about half of infected children under 10 had caught the virus from their mothers during birth.
The second claim, made by some members, was that birth-dose vaccination mainly protects other, higher-risk people. PolitiFact called that misleading. The point of the birth dose is to protect newborns, who are especially vulnerable. The virus attacks the liver, and infected infants have a 90% chance of developing the chronic form. A quarter of those babies go on to die prematurely from the disease as adults. Untreated chronic infection can cause cirrhosis and death and is a leading cause of liver cancer. Treatment can blunt the worst effects, but there is no cure. Dr. James Campbell, a pediatric infectious disease doctor at the University of Maryland, put the change in numbers: "We used to have 18,000 or 20,000 kids a year being born with this, a quarter of them going on to have liver cancer. We now have almost none."
The third point was that infection rates are already low. That is true, and PolitiFact's argument is that the vaccine is the reason. Before the vaccine, around 200,000 to 300,000 people were infected each year, including about 20,000 children. Overall cases have since fallen to around 14,000 annually. In 2022 the CDC reported 252 new chronic infections among people up to age 19, or 0.4 per 100,000 children. Dr. H. Cody Meissner, a committee member who voted against the change, said the disease "has become a victim of the vaccine." He warned that it is a mistake to infer the schedule can be altered because little disease is visible, because infections will return.
The fourth claim was comparative. Members repeatedly pointed to other countries, Denmark among them, to justify dropping the universal recommendation. The U.S. is not an outlier, though. In September 2025 the CDC reported that of the 194 WHO member states, 116 recommend a universal hepatitis B birth dose. Denmark's schedule covers 10 diseases but not hepatitis B, and it recommends the vaccine only for babies of infected mothers, according to the European Centre for Disease Prevention and Control. Yet Denmark has a national health care system. The U.S. does not, which makes prenatal care harder to access and records harder to track across doctors, and it has lower rates of prenatal hepatitis B screening.
What to watch now is whether the new guidance, with first doses pushed to 2 months or later for many babies, shows up in infection rates among the youngest children.
Citazioni salienti
It's a mistake to say that because we're not seeing much disease, we can alter the schedule, because we will see hepatitis B infections come back.— Dr. H. Cody Meissner, ACIP member (paraphrased)
We used to have 18,000 or 20,000 kids a year being born with this... We now have almost none.— Dr. James Campbell, University of Maryland
Vuoi la storia completa?
Leggi l'originale su PBS News ↗
Health & Medicine